PNC Financial Services Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
AC
PNC Financial Services Group's HRMY Position: Q2 2026 in Review
PNC Financial Services Group increased its Harmony Biosciences (HRMY) stake by 15% in Q2 2026, buying an estimated $10.7K and bringing the position to 2,570 shares worth $93.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2970.
PNC Financial Services Group first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $233K in Q2 2023. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- PNC Financial Services Group held 2,570 shares of Harmony Biosciences worth $93.6K as of Q2 2026.
- PNC Financial Services Group bought 338 Harmony Biosciences shares in Q2 2026, an estimated $10.7K.
- Harmony Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2970 holding.
- PNC Financial Services Group first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
- PNC Financial Services Group's Harmony Biosciences position peaked at $233K in Q2 2023.
- 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.